Tag: Botulinum Toxin

Use of Botulinum Toxin for the Correction of Mild Ptosis

Use of Botulinum Toxin for the Correction of Mild Ptosis

| April 1, 2018

by Hamzah Mustak, MD; Michael Rafaelof, BS; Robert Alan Goldberg, MD; and Daniel Rootman, MD Drs. Mustak, Goldberg, and Rootman and Mr. Rafaelof are with the Stein Eye Institute, Division of Orbital and Oculoplastic Surgery at the University of California, Los Angeles in Los Angeles, California. Dr. Mustak is also with the Groote Schuur Hospital, […]

Continue Reading

Pan-Asian Consensus— Key Recommendations for Adapting the World Congress of Dermatology Consensus on Combination Treatment with Injectable Fillers, Toxins, and Ultrasound Devices in Asian Patients

Pan-Asian Consensus— Key Recommendations for Adapting the World Congress of Dermatology Consensus on Combination Treatment with Injectable Fillers, Toxins, and Ultrasound Devices in Asian Patients

| August 1, 2017

by Yates Y.Y. Chao, MD; Chiranjiv Chhabra, MBBS, DVD; Niamh Corduff, MBBS, FRACS; Sabrina Guillen FABI, MD; Martina Kerscher, MD; Stephanie C.K. Lam, MBChB; Tatjana Pavicic, MD; Berthold Rzany, MD, ScM; Peter H.L. Peng, MD; Atchima Suwanchinda, MD; Fang-Wen Tseng, MD; and Kyle K. Seo, MD, PhD Dr. Chao is with Chao and Chiu Institute […]

Continue Reading

Oily Skin: A Review of Treatment Options

Oily Skin: A Review of Treatment Options

| August 1, 2017

by Dawnielle C. Endly, DO, and Richard A. Miller, DO Dr. Endly is with Advanced Dermatology Skin Cancer and Laser Surgery Center in Aurora, Colorado. Dr. Miller is with Nova Southeastern University/Largo Medical Center, Dermatology Residency Program and Bay Dermatology and Cosmetic Surgery in Largo, Florida. J Clin Aesthet Dermatol. 2017;10(8):49–55 Funding: No funding was […]

Continue Reading

A Novel Long-term Therapy of Facial Synkinesis with Botulinum Neurotoxins Type A and Fillers

A Novel Long-term Therapy of Facial Synkinesis with Botulinum Neurotoxins Type A and Fillers

| March 17, 2011 | 0 Comments

Adam Wiener, DO; Khasha Touloei, OMS3; Bradley P. Glick, DO, MPH, FAOCD Adam Wiener, DO, and Bradley P. Glick, DO, MPH, FAOCD, are from Wellington Regional Medical Center, Wellington, Florida. Khasha Touloei, OMS3, is from Western University of Health Sciences, Pomona, California.

Continue Reading

Topical Botulinum Toxin

| March 5, 2010 | 0 Comments

Ashley Collins, MD; Department of Biochemistry, North Carolina State University; Adnan Nasir, MD, Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina Abstract Nanotechnology is a rapidly growing discipline that capitalizes on the unique properties of matter engineered on the nanoscale. Vehicles incorporating nanotechnology have led to great strides in drug delivery, allowing […]

Continue Reading

The Botulinum Toxin Experience: Results of a Patient Self-Report Questionnaire

The Botulinum Toxin Experience: Results of a Patient Self-Report Questionnaire

| November 5, 2009 | 0 Comments

Richard G. Fried, MD, PhD, Clinical Director, Yardley Dermatology Associates, Yardley, Pennsylvania; Wm. Philip Werschler, MD, Assistant Clinical Professor of Medicine and Dermatology, University of Washington, Seattle, Washington; Tracy Floirendo, MA, Yardley Dermatology Associates, Yardley, Pennsylvania

Continue Reading